Additionally, more than 70% of DFU patients will ultimately require lower limb amputation, imposing a heavy financial burden and severe impairment to patients quality of life [160]
(84) highlighted the neuroprotective potential of GLP-1 RAs, particularly in reducing protein aggregation and improving mitochondrial function
Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications approved by the FDA for treating type 2 diabetes and, in some formulations, for chronic weight management
By IQVIAs latest tracking, China accounts for a large share of global generic semaglutide manufacturing: there are currently 74 Chinese developers, including CDMOs and full developers, with many using synthetic approaches, alongside growing manufacturing activity in India and other geographies
While experimental transdermal systems show promise in animal studies, commercially available patches typically contain herbal ingredients rather than actual GLP-1 medications